Parth Shah, Pharm.D., Mba Email & Phone Number

Los Angeles, Ca, Us

Thousand Oaks, Ca, Us

In August 2022, Amgen announced a $3.7B acquisition of biotech ChemoCentryx (CCXI) primarily for novel complement inhibitor Tavneos (avacopan). Acquisition closed in October 2022, as the franchise GM I led commercial integration, organizational build/redesign and the turnaround of Tavneos launch from pre-close period to 2+ years post-acquisition - resulting in 100%+ sales growth CAGR and 4X new patient start run rates • Developed a rare disease operating model including distribution/channel, market access, medical affairs, patient support, sales, & marketing • Drove Tavneos inline go to market strategy, launch/repositioning, lifecycle management/commercialization (indications, formulations, RWE) • Additional dual role as Chair of Joint Commercial Committee for global commercialization alliance with CSL Vifor & global product team Commercial Lead• Developed and lead national field thought leader liaison/strategic customer engagement team across rheumatology, nephrology and other specialties

Thousand Oaks, Ca, Us

GM with ~2B P&L ownership for major provider and payer contracted oncology products — Led integrated cross functional commercial organization including pricing/contracting to deliver for customers and patients across our portfolio of 5 marketed products in biosimilar marketplaces: MVASI® (bevacizumab-awwb), KANJINTI (trastuzumab-anns), RIABNI™ (rituximab-arrx) and innovative medicines Neulasta® (pegfilgrastim) Onpro®, NEUPOGEN® (filgrastim) injection. Our team's efforts also include planning for ABP 938, an investigational biosimilar to EYLEA® (aflibercept) in ophthalmology and ABP 959, an investigational biosimilar to SOLIRIS® (eculizumab) in multiple rare diseases. At Amgen, we believe that high-quality biosimilars, coupled with robust competition, provide patients with needed treatment options, help contain costs and contribute to long-term health care system resilience.

Thousand Oaks, Ca, Us

~$2B P&L portfolio brand lead for supportive care and therapeutics — Led multiple brand/commercial and cross functional teams for two approved medicines XGEVA® and Nplate® (indications across solid tumors, multiple myeloma, rare autoimmune disease, adults and pediatrics)

Thousand Oaks, Ca, Us

Headed strategic P&L activities for $6B portfolio of 10+ oncology/hematology products; Chief of Staff for SVP of US Oncology• Spearheaded major organizational transformations from strategy/design to operational implementation. • Architected key capability areas including inline portfolio and launch sales force structures, account management model, diagnostic engagement model, virtual selling organization, omnichannel marketing • Executed OPEX redeployment and restructuring by dynamically orchestrating project teams including HR/legal/finance

Thousand Oaks, Ca, Us

Nplate (Autoimmune rare disease / non-malignant hematology, $400M sales)• Led direct and cross functional team to shape strategy, launch readiness, sales execution, omnichannel engagement & support services resulting in above target double digit growth

Thousand Oaks, Ca, Us

Cross functional US launch lead for novel delivery system (Repatha Pushtronex - Amgen's first patient self-administered wearable injector / infusion pump device)

Thousand Oaks, Ca, Us

Headed various medical marketing efforts as part of core Repatha US launch team including FH (rare disease) and hypercholesterolemia

Thousand Oaks, Ca, Us

Led global launch strategic planning and HCP/patient execution activities for Repatha including FH (rare disease) and hypercholesterolemia

Thousand Oaks, Ca, Us

Portfolio sales and account management responsibility for clinics, hospitals, academic medical center

Washington, Dc, Us

Outpatient primary care/chronic disease service (diabetes, dyslipidemia, asthma, anticoagulation, HIV)

USC Norris Comprehensive Cancer Center: oncology, hematology and transplant inpatient pharmacy service, hospital business operations

Us

Pharmacy Benefit Management (PBM) unit of UnitedHealth: • Collaborated with clinical services (formulary operations, P&T, analytics), industry relations (contracting), and client team to lead projects for Medicare/Commercial business

ICU pharmacotherapy, drug information service in academic medical center setting

Deerfield, Il, Us

Retail pharmacy clinical and business operations

Cerritos, California, Us

Home infusion and specialty pharmacy (oncology, infectious disease, specialty care): Process improvement projects across clinical, managed care and sales operations

Thousand Oaks, Ca, Us

Led cross functional identification and evaluation of oncology lifecycle management opportunities

Thousand Oaks, Ca, Us

Managed global ovarian carcinoma pipeline payer research to inform value proposition development & pricing

Thousand Oaks, Ca, Us

Led US/EU inflammation pipeline research & analytics effort to support pricing, access, and value evidence generation planning

Thousand Oaks, Ca, Us

Created cross portfolio pricing, access, and reimbursement situation analysis to support Mexico market entry

Mba, Finance, Marketing

Doctorate (Pharmd), Clinical Pharmacy

Bachelor Of Arts, Biological Sciences

Bachelor Of Science, Public Policy, Management, And Planning